Cargando…

Mortality and guideline‐directed medical therapy in real‐world heart failure patients with reduced ejection fraction

OBJECTIVE: To estimate the prevalence of guideline‐directed medical therapy (GDMT) in commercially insured US patients with heart failure with reduced ejection fraction (HFrEF) and examine the effect of GDMT on all‐cause mortality. GDMT for HFrEF includes pharmacologic therapies such as β‐blockers (...

Descripción completa

Detalles Bibliográficos
Autores principales:	McCullough, Peter A., Mehta, Hirsch S., Barker, Colin M., Van Houten, Joanna, Mollenkopf, Sarah, Gunnarsson, Candace, Ryan, Michael, Cork, David P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals, Inc. 2021
Materias:	Quality and Outcomes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427999/ https://www.ncbi.nlm.nih.gov/pubmed/34342033 http://dx.doi.org/10.1002/clc.23664

Ejemplares similares

Impact of mitral regurgitation on cardiovascular hospitalization and death in newly diagnosed heart failure patients
por: Cork, David P., et al.
Publicado: (2020)

Gender differences in acute myocardial infarction—A nationwide German real‐life analysis from 2014 to 2017
por: Kuehnemund, Leonie, et al.
Publicado: (2021)

Percutaneous coronary intervention and 30‐day unplanned readmission with chest pain in the United States (Nationwide Readmissions Database)
por: Sykes, RobertA., et al.
Publicado: (2021)

Anticoagulation in patients with atrial fibrillation and heart failure: Insights from the NCDR PINNACLE‐AF registry
por: Contreras, Johanna P., et al.
Publicado: (2019)

Cost‐Effectiveness of LDL‐C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States
por: Gandra, Shravanthi R., et al.
Publicado: (2016)

Characterizing Major Bleeding in Patients With Nonvalvular Atrial Fibrillation: A Pharmacovigilance Study of 27 467 Patients Taking Rivaroxaban
por: Tamayo, Sally, et al.
Publicado: (2015)

Association between anxiety and clinical outcomes in Chinese patients with myocardial infarction in the absence of obstructive coronary artery disease
por: He, Chao‐Jie, et al.
Publicado: (2020)

Time‐trends and treatment gaps in the antithrombotic management of patients with atrial fibrillation after percutaneous coronary intervention: Insights from the CHUM AF‐STENT Registry
por: Boivin‐Proulx, Laurie‐Anne, et al.
Publicado: (2019)

Diabetes association with self‐reported health, resource utilization, and prognosis post‐myocardial infarction
por: Nicolau, José C., et al.
Publicado: (2020)

The impact of short hospital stay on prognosis after acute myocardial infarction: An analysis from the ACSIS database
por: Tomer, Orr, et al.
Publicado: (2021)

Device infections related to cardiac resynchronization therapy in clinical practice–An analysis of its prevalence, risk factors and routine surveillance at a single center university hospital
por: Ostrowska, Bozena, et al.
Publicado: (2021)

Development and Validation of a High‐Quality Composite Real‐World Mortality Endpoint
por: Curtis, Melissa D., et al.
Publicado: (2018)

Working Agenda for Black Mothers: A Position Paper From the Association of Black Cardiologists on Solutions to Improving Black Maternal Health
por: Bond, Rachel M., et al.
Publicado: (2021)

Whole blood transcriptomic profiling identifies molecular pathways related to cardiovascular mortality in heart failure
por: Nath, Mintu, et al.
Publicado: (2022)

Extraction of Ejection Fraction from Echocardiography Notes for Constructing a Cohort of Patients having Heart Failure with reduced Ejection Fraction (HFrEF)
por: Wagholikar, Kavishwar B., et al.
Publicado: (2018)

Rethinking Medicare Payment Adjustments for Quality
por: Averill, Richard F., et al.
Publicado: (2016)

Prevalence and prognostic value of ventricular conduction delay in heart failure with preserved ejection fraction
por: Weerts, J, et al.
Publicado: (2023)

The economic considerations of patients and caregivers in choice of dialysis modality
por: Walker, Rachael C., et al.
Publicado: (2016)

Real‐world eligibility for vericiguat in decompensated heart failure with reduced ejection fraction
por: Oh, Jaewon, et al.
Publicado: (2022)

ASH Research Collaborative: a real-world data infrastructure to support real-world evidence development and learning healthcare systems in hematology
por: Wood, William A., et al.
Publicado: (2021)

Real‐world clinical diagnostics of heart failure patients with reduced or preserved ejection fraction
por: Huusko, Jenni, et al.
Publicado: (2020)

Rheumatologists’ perspective on hydroxychloroquine guidelines
por: Winebrake, James, et al.
Publicado: (2020)

Real-world burden of systemic lupus erythematosus in the USA: a comparative cohort study from the Medical Expenditure Panel Survey (MEPS) 2016–2018
por: Grabich, Shannon, et al.
Publicado: (2022)

Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction: Real-World Experience from Italy (the REAL.IT Study)
por: Di Lenarda, Andrea, et al.
Publicado: (2023)

Real-world treatment patterns, healthcare resource utilisation and costs in patients with systemic lupus erythematosus treated with belimumab: a retrospective analysis of claims data in the USA
por: Bell, Christopher F, et al.
Publicado: (2020)

Evaluation of Adherence to Guideline for Heart Failure with Reduced Ejection Fraction in Heart Failure with Preserved Ejection Fraction and with or without Atrial Fibrillation
por: Ahn, Min-Soo, et al.
Publicado: (2021)

Frequency, severity and costs of flares increase with disease severity in newly diagnosed systemic lupus erythematosus: a real-world cohort study, United States, 2004–2015
por: Hammond, Edward R, et al.
Publicado: (2021)

Left ventricular hypertrophy, dilatation and ejection fractions predict ventricular tachycardia in amyloid transthyretin cardiomyopathy
por: Knoll, K, et al.
Publicado: (2023)

Disease and economic burden increase with systemic lupus erythematosus severity 1 year before and after diagnosis: a real-world cohort study, United States, 2004–2015
por: Jiang, Miao, et al.
Publicado: (2021)

Real-world comparative effectiveness of acalabrutinib and ibrutinib in patients with chronic lymphocytic leukemia
por: Roeker, Lindsey E., et al.
Publicado: (2023)

Ventricular tachyarrhythmia detection by implantable loop recording in patients with heart failure and preserved ejection fraction: the VIP‐HF study
por: van Veldhuisen, Dirk J., et al.
Publicado: (2020)

Estimated mortality rates of individuals with sickle cell disease in Brazil: real-world evidence
por: Cançado, Rodolfo Delfini, et al.
Publicado: (2023)

Early experience of Sacubitril–Valsartan in heart failure with reduced ejection fraction in real‐world clinical setting
por: Nordberg Backelin, Charlotte, et al.
Publicado: (2020)

Characterizing a Clinical Trial – Representative, Real-World Population with Heart Failure with Reduced Ejection Fraction
por: Wells, Quinn S, et al.
Publicado: (2022)

Dose titration of sacubitril/valsartan for heart failure with reduced ejection fraction: a real‐world study
por: Wang, Chen, et al.
Publicado: (2023)

Infection hospitalisation in systemic lupus in Sweden
por: Simard, Julia F, et al.
Publicado: (2021)

Clinical outcomes associated with anti‐obesity medications in real‐world practice: A systematic literature review
por: Ahmad, Nadia N., et al.
Publicado: (2021)

Results of VOICE: a global survey of disease-specific knowledge and perspectives of real-world patients with CLL
por: Tam, Constantine, et al.
Publicado: (2023)

Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus
por: Vázquez-Otero, Ileana, et al.
Publicado: (2020)

Quick Systemic Lupus Activity Questionnaire (Q-SLAQ): a simplified version of SLAQ for patient-reported disease activity
por: Svenungsson, Elisabet, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_63c57hb1rn03dfreltmln13rlq